OncoLink Cancer Treatment and Resources
Link to OncoLink

Bladder Cancer in Dogs

Lili Duda, VMD
Ultima Vez Modificado: 1 de noviembre del 2001

Question
Dear OncoLink "Ask the Experts,"
Our 10 year old Sheltie was just diagnosed with bladder cancer. The tumor appears to be about 1 1/2" and is located near the opening of the urethra. The bladder appears to be abnormally shaped. Could you possibly outline the likely treatment options?


Answer
Lili Duda, VMD, Editor of the OncoLink Veterinary Oncology Section, responds:

Unfortunately, most bladder tumors are not diagnosed until they have become too large, or are in a location where surgery is not a treatment option. Treatment efforts are aimed at controlling the clinical signs (such as straining to urinate, blood in the urine, etc.) for as long as possible (which usually means months, rather than years).

The traditional chemotherapy drugs such as Adriamycin and Cytoxan, or cisplatin are the standard treatment for this tumor. These drugs do have some effectiveness in controlling bladder tumors. A newer approach uses a non-steroidal anti-inflammatory drug called piroxicam (tradename Feldene, which is similar to drugs like ibuprofen) which has shown anti-tumor effects against transitional cell carcinoma, as well as decreasing inflammation associated with the tumor.

Additionally, your dog should be evaluated for the presence of a urinary tract infection (urinalysis, culture and sensitivity) and treated with antibiotics as needed. Kidney function should be monitored periodically as well (via blood chemistries).

Each of the mentioned treatments has certain manageable risks, which must be weighed against potential benefits and your dog's overall health. These should be discussed with your veterinarian or veterinary oncologist, along with any other questions or concerns you may have.

If you or your veterinarian have not already done so, please consult a qualified veterinary oncologist to further explore the treatment options for your pet.


OncoLink I wish u knew...

Ms. Bruning talks about working in development for a cancer center and how this translates to hope in cancer care. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS